MOMETASONE and COUGH

Overview

COUGH is the #5 most commonly reported adverse reaction for MOMETASONE, manufactured by Amneal Pharmaceuticals LLC. There are 1,178 FDA adverse event reports linking MOMETASONE to COUGH. This represents approximately 2.4% of all 48,940 adverse event reports for this drug.

Patients taking MOMETASONE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for MOMETASONE, but still significant enough to appear in the safety profile.

Other Side Effects of MOMETASONE

In addition to cough, the following adverse reactions have been reported for MOMETASONE:

• DYSPNOEA — 1,731 reports
• ASTHMA — 1,553 reports
• DRUG INEFFECTIVE — 1,477 reports
• HEADACHE — 1,394 reports
• FATIGUE — 1,099 reports
• OFF LABEL USE — 1,035 reports
• WHEEZING — 966 reports
• GASTROOESOPHAGEAL REFLUX DISEASE — 965 reports
• PRURITUS — 905 reports
• NAUSEA — 893 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does MOMETASONE cause COUGH?

COUGH has been reported as an adverse event in 1,178 FDA reports for MOMETASONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with MOMETASONE?

COUGH accounts for approximately 2.4% of all adverse event reports for MOMETASONE, making it a notable side effect.

What should I do if I experience COUGH while taking MOMETASONE?

If you experience cough while taking MOMETASONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages